Fennec Pharmaceuticals Inc logo

Fennec Pharmaceuticals Inc

C$ 10.00 (0%) Sep 29
P/E:
At Loss
P/B:
23.81
Market Cap:
C$ 260.67M ($ 190.15M)
Enterprise V:
C$ 247.05M ($ 180.21M)
Volume:
-
Avg Vol (2M):
991.00
Also Trade In:
Volume:
-
Market Cap C$:
260.67M
Market Cap $:
190.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
991.00
Enterprise Value C$:
247.05M
Enterprise Value $:
180.21M
PB Ratio:
23.81
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.
Name Current Vs Industry Vs History
Cash-To-Debt 2.99
Equity-to-Asset 0.55
Debt-to-Equity 0.58
Debt-to-EBITDA -0.29
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.85
9-Day RSI 52.18
14-Day RSI 55.19
6-1 Month Momentum % 24.9
12-1 Month Momentum % -24.63

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.12
Quick Ratio 5.12
Cash Ratio 4.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.3

Financials (Next Earnings Date:2022-11-10 Est.)

TSX:FRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0
EPS (TTM) (C$) -0.841
Beta 0
Volatility % 71.09
14-Day RSI 55.19
14-Day ATR (C$) 0.29869
20-Day SMA (C$) 9.838
12-1 Month Momentum % -24.63
52-Week Range (C$) 4.95 - 13.25
Shares Outstanding (Mil) 26.07

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Fennec Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Fennec Pharmaceuticals Inc Analysis

Share your research